GB201313909D0 - Powder formulation - Google Patents
Powder formulationInfo
- Publication number
- GB201313909D0 GB201313909D0 GBGB1313909.2A GB201313909A GB201313909D0 GB 201313909 D0 GB201313909 D0 GB 201313909D0 GB 201313909 A GB201313909 A GB 201313909A GB 201313909 D0 GB201313909 D0 GB 201313909D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- powder formulation
- formulation
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1313909.2A GB201313909D0 (en) | 2013-08-02 | 2013-08-02 | Powder formulation |
CA2898922A CA2898922A1 (en) | 2013-03-07 | 2014-03-07 | Powder formulation |
EP14709244.9A EP2964252A2 (en) | 2013-03-07 | 2014-03-07 | Powder formulation comprising thrombin and fibrinogen |
PCT/EP2014/054477 WO2014135689A2 (en) | 2013-03-07 | 2014-03-07 | Powder formulation |
AU2014224594A AU2014224594B2 (en) | 2013-03-07 | 2014-03-07 | Powder formulation comprising thrombin and fibrinogen |
MX2015011623A MX2015011623A (en) | 2013-03-07 | 2014-03-07 | Powder formulation comprising thrombin and fibrinogen. |
US14/773,212 US20160015792A1 (en) | 2013-03-07 | 2014-03-07 | Powder formulation comprising thrombin and fibrinogen |
EA201591657A EA201591657A1 (en) | 2013-03-07 | 2014-03-07 | POWDER COMPOSITION |
JP2015560712A JP2016510059A (en) | 2013-03-07 | 2014-03-07 | Powder formulation |
CN201480012686.4A CN105188740A (en) | 2013-03-07 | 2014-03-07 | Powder formulation comprising thrombin and fibrinogen |
BR112015017463A BR112015017463A8 (en) | 2013-03-07 | 2014-03-07 | POWDER FORMULATION |
IL240902A IL240902A0 (en) | 2013-03-07 | 2015-08-27 | Powder formulation comprising thrombin and fibrinogen |
US16/408,678 US20190269764A1 (en) | 2013-02-08 | 2019-05-10 | Powder formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1313909.2A GB201313909D0 (en) | 2013-08-02 | 2013-08-02 | Powder formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201313909D0 true GB201313909D0 (en) | 2013-09-18 |
Family
ID=49224104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1313909.2A Ceased GB201313909D0 (en) | 2013-02-08 | 2013-08-02 | Powder formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201313909D0 (en) |
-
2013
- 2013-08-02 GB GBGB1313909.2A patent/GB201313909D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288961A (en) | Pharmaceutical compositions | |
ZA201602461B (en) | Powder coating composition | |
EP3065716C0 (en) | Formulations | |
PL2943181T3 (en) | Pharmaceutical compositions | |
EP2970924A4 (en) | Phytase formulation | |
GB201319792D0 (en) | Formulations | |
HK1214951A1 (en) | Ophthalimic formulations | |
GB201320432D0 (en) | Novel formulation | |
GB201322948D0 (en) | Improved formulation | |
HRP20171888T1 (en) | Pharmaceutical compositions | |
GB2517232B (en) | Formulation | |
GB201317718D0 (en) | Novel formulation | |
GB2518724B (en) | Edible formulation | |
GB201304699D0 (en) | Pharmaceutical compositions | |
GB201313909D0 (en) | Powder formulation | |
HK1209981A1 (en) | Formulation | |
GB201304145D0 (en) | Powder formulation | |
GB201304146D0 (en) | Powder formulation | |
IL244316A0 (en) | Novel drug formulation | |
GB201303337D0 (en) | Powder | |
GB201312347D0 (en) | Formulation | |
GB201317717D0 (en) | Novel formulation | |
TWM476477U (en) | Improved formulation for grain powder | |
GB201322181D0 (en) | Feed formulation | |
GB201321280D0 (en) | Feed formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |